G3BP2 and infection: After demonstrating that knocking out G3BP2 was also insufficient to inhibit SG formation, we developed a G3BP1 and G3BP2 dKO cell line, which successfully stopped SG from forming during RSV cbVG-high infection (Fig 5D).